http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005521744-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
filingDate | 2003-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2005521744-A |
titleOfInvention | 6- (4-Substituted-anilino) pyrimidine derivatives, process for producing the same, and antiviral pharmaceutical composition comprising the same as an active ingredient |
abstract | The present invention relates to a 6- (4-substituted-anilino) pyrimidine derivative useful as an antiviral agent. More specifically, the present invention has the following chemical formula (I) excellent in the growth inhibitory effect of hepatitis C virus (HCV). ), A novel 6- (4-substituted-anilino) pyrimidine derivative and a pharmaceutically acceptable salt thereof, a production method thereof, and an antiviral pharmaceutical composition containing the compound as an active ingredient. The 6- (4-substituted-anilino) pyrimidine derivatives according to the present invention are useful for the prevention and treatment of hepatitis C because of their excellent inhibitory effect on the growth of hepatitis C virus (HCV). Here, in the following chemical formula (I), R represents a C 1 -C 4 linear or branched alkoxycarbonyl group, a heterocyclic carbonyl group, or a carboxyalkyl group. [Chemical 1] |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010505797-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012500278-A |
priorityDate | 2002-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 178.